Profil
Andrew B. Udell is Chief Commercial Officer at Actinogen Medical Ltd. since 2024.
Formerly, Mr. Udell was President-North America Region at Calliditas Therapeutics AB from 2021 to 2024 and Vice President-North America Commercial at NeuroDerm Ltd. from 2017 to 2018.
Mr. Udell completed undergraduate studies at Lehigh University and earned an MBA from the University of Connecticut.
Postes actifs de Andrew Udell
| Sociétés | Poste | Début |
|---|---|---|
| ACTINOGEN MEDICAL LIMITED | Corporate Officer/Principal | 15/10/2024 |
Anciens postes connus de Andrew Udell
| Sociétés | Poste | Fin |
|---|---|---|
| CALLIDITAS THERAPEUTICS AB | Corporate Officer/Principal | 07/01/2024 |
| NEURODERM LTD | Corporate Officer/Principal | 01/06/2018 |
Formation de Andrew Udell
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Lehigh University
Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Connecticut
University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Calliditas Therapeutics AB
Calliditas Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
NeuroDerm Ltd.
NeuroDerm Ltd. BiotechnologyHealth Technology Develops next-generation drug-device combination solutions for central nervous system disorders | Health Technology |
Actinogen Medical Ltd.
Actinogen Medical Ltd. Pharmaceuticals: OtherHealth Technology Manufactures and develops biotechnology compounds | Health Technology |
















